Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07647354 · ClinicalTrials.gov registry record
Mako-MORE Registry
A clinical trial, sponsored by Stryker Orthopaedics.
- Not yet
- Registry status
- 950
- Enrollment target
NCT07647354: Clinical Trial study, sponsored by Stryker Orthopaedics.
NCT07647354 is a clinical trial that has not yet begun recruiting, run by Stryker Orthopaedics. The registered enrollment target is 950 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07647354 has not yet begun recruiting, sponsored by Stryker Orthopaedics.
- NOT YET RECRUITING
- Registry status
- 950 participants
- Enrollment target
Study Summary
This is a prospective, post-market, multi-center, registry-based observational study designed to collect real-world clinical data on patients undergoing joint arthroplasty with Stryker implants, with or without the use of the Mako Robotic-Arm Assisted System. The registry will collect prospective data on patient characteristics, procedural details, patient-reported outcomes, radiographic assessments, and adverse events. Patients will be enrolled into procedure-specific cohorts and followed for up to five years postoperatively.
Primary Outcome
To evaluate survival rate at 2-years postoperative for Stryker devices implanted with the Mako Robotic-Arm Assisted System. Survival is defined as the absence of revision for implanted devices.
Interventions
- DEVICE Mako Robotic-Arm Assisted Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2037-03-15 |
What is known before NCT07647354 opens enrollment
NCT07647354 is an observational study that tracks outcomes without assigning an intervention. The registered 950 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mako Robotic-Arm Assisted Arthroplasty is the first listed.
NCT07647354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07647354 about?
NCT07647354 is a clinical study titled "Mako-MORE Registry". This is a prospective, post-market, multi-center, registry-based observational study designed to collect real-world clinical data on patients undergoing joint arthroplasty with Stryker implants, with or without the use of the Mako Robotic-Arm Assisted System. The registry will collect prospective da...
What is the current status of trial NCT07647354?
This trial is currently not yet recruiting. The enrollment target is 950 participants. The study started on 2026-06-15. Estimated completion is 2037-03-15.
What interventions are being tested in trial NCT07647354?
The interventions under investigation include: Mako Robotic-Arm Assisted Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT07647354?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI